ConductScience.org, home

Gene · 722

Papers2,921

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 2,921

Download this page as JSON
TitleJournalYearPMIDFound bySource
Insights into Medication-Induced Osteonecrosis of the Jaw Through the Application of Salivary Proteomics and Bioinformatics.Int J Mol Sci202439596473PubTator, text miningPubMed
Biophysical characterization and structural insights of leptospiral complement regulator-acquiring protein A.Biochem Biophys Res Commun202439556937PubTator, text miningPubMed
Exosomes derived from platelet-rich plasma present a novel potential in repairing knee articular cartilage defect combined with cyclic peptide-modified β-TCP scaffold.J Orthop Surg Res202439497084PubTator, text miningPubMed
C4b-Binding Protein and Factor H Attenuate NLRP3 Inflammasome-Mediated Signalling Response during Group A Streptococci Infection in Human Cells.J Innate Immun202439496236PubTator, text miningPubMed
Multiomics Profiling of Plasma Reveals Molecular Alterations Prior to a Diagnosis with Stroke Among Chinese Hypertension Patients.J Proteome Res202439466185PubTator, text miningPubMed
Altered Expressions of IL-15, IFNG, and HPRT1 Genes in the Thin Endometria of Patients with Reproductive Disorders: A Prospective Comparative Study.J Clin Med202439458137PubTator, text miningPubMed
Protein biomarkers in assessing kidney quality before transplantation‑current status and future perspectives (Review).Int J Mol Med202439370783PubTator, text miningPubMed
Altered Expression of C4BPA and CXCL1 Genes in the Endometrium of Patients with Recurrent Implantation Failure after In Vitro Fertilization and Thin Endometrium.Diagnostics (Basel)202439272751PubTator, text miningPubMed
Functional evaluation of rare variants in complement factor I using a minigene assay.Front Immunol202439238643PubTator, text miningPubMed
Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus.Eur J Immunol202439165045PubTator, text miningPubMed
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism.Biochem Pharmacol202439098732PubTator, text miningPubMed
In Vitro Investigation of Pulsed Electromagnetic Field Stimulation (PEMF) with MAGCELL® ARTHRO on the Regulatory Expression of Soluble and Membrane-Bound Complement Factors and Inflammatory Cytokines in Immortalized Synovial Fibroblasts.
J Pers Med202439063955PubTator, text miningPubMed
Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signatures.J Cancer Res Clin Oncol202439034327PubTator, text miningPubMed
Integrative analysis reveals different feature of intrahepatic cholangiocarcinoma subtypes.Liver Int202438924592PubTator, text miningPubMed
Proteomics Clustering Research of ITRAQ Markers in Plasma of AIDS Patients with Different Chinese Medicine Syndromes.Iran J Public Health202438894847PubTator, text miningPubMed
Ramadan intermittent fasting is associated with improved anticoagulant activity among healthy people: a case-control study.Sci Rep202438879576PubTator, text miningPubMed
Conservation of C4BP-binding sequence patterns in Streptococcus pyogenes M and Enn proteins.J Biol Chem202438879009PubTator, text miningPubMed
Ultrasensitive dynamic light scattering immunodetection of alpha-fetoprotein using heptamer-amplified nanoparticle crosslinking aggregation.Mikrochim Acta202438869719PubTator, text miningPubMed
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators.Front Immunol202438817607PubTator, text miningPubMed
Higher-order structure and proteoforms of co-occurring C4b-binding protein assemblies in human serum.EMBO J202438811852PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/722/papers?page=5